lymphomatoid granulomatosis - HEALTHY
In a study spanning almost three decades, the use of interferon alfa-2b led to durable remission for patients with low-grade lymphomatoid granulomatosis and increased overall survival compared with ... EurekAlert!: NIH study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a ... NIH study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis The current histological criteria for the diagnosis of lymphomatoid granulomatosis (LYG) are reviewed and summarized.
Context Explanation
The majority of patients present with multiple bilateral nodules involving the ... News Medical: Novel immunotherapy-based approach for low-grade lymphomatoid granulomatosis improves patient survival Lymphomatoid granulomatosis causes an overproduction of white blood cells known as B lymphocytes. Patients typically have lesions in the lungs, central nervous system, skin, liver, and kidneys. Nature: Course of IL-2-inducible T-cell kinase deficiency in a family: lymphomatoid granulomatosis, lymphoma and allogeneic bone marrow transplantation in one sibling; and death in the ...
Image Collection
Insight Material
Course of IL-2-inducible T-cell kinase deficiency in a family: lymphomatoid granulomatosis, lymphoma and allogeneic bone marrow transplantation in one sibling; and death in the ... ascopubs.org: Long-Term Remission After Multiple Relapses in an Elderly Patient With Lymphomatoid Granulomatosis After Rituximab and High-Dose Cytarabine Chemotherapy Without Stem-Cell ... Long-Term Remission After Multiple Relapses in an Elderly Patient With Lymphomatoid Granulomatosis After Rituximab and High-Dose Cytarabine Chemotherapy Without Stem-Cell ...